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Summary The relationship between various diseases and immunisations and the risk of multiple myeloma
was analysed using data from a hospital-based case-control study conducted in Northern Italy on 117 patients
with multiple myeloma and 477 controls. Associations were observed for clinical history of scarlet fever
(relative risk, RR = 2.0; 95% confidence interval, CI = 1 .1-3.9), tuberculosis (RR = 2.3; 95% CI = 0.9-5.7)
and BCG immunisation (RR = 3.0; 95% CI = 1.4-6.4). The relative risk was 1.8 (95% CI = 0.9-3.5) for
episodes of Herpes zoster infection, but most of the excess cases occurred within 10 years of diagnosis,
suggesting that this might have been an early manifestation of the disease. No association emerged for
common childhood viral infections or any other immunisation practice. When various classes of infectious or
inflammatory diseases were grouped together according to their aetiology, there was a significant positive
association with chronic bacterial illnesses (RR = 1.8; 95% CI = 1.1-2.8), and the relative risk estimates
increased with the number of bacterial diseases. The trend in risk with number of diseases was significant
(2= 4.5, P = 0.03). A negative association was found between allergic conditions and risk of multiple
myeloma (RR = 0.6; 95% CI = 0.3 -1.0).
Multiple myeloma is a malignant neoplasm affecting B
lymphocytes. In Italy, death certification rates (on the basis
of the world standard population) in the mid 1980's were
respectively 1.8 and 1.3 per 100,000 in males and females,
corresponding to a total of approximately 1,500 deaths per
year (La Vecchia et al., 1990a). Although multiple myeloma
is a rare malignancy, its mortality has substantially increased
in Italy (+ 600% between 1956 and 1984) (La Vecchia et al.,
1990a), as in most developed countries (Cuzick et al., 1983).
However, these changes could reflect more complete ascer-
tainment of cases of the disease rather than a true rise in
incidence. In the last few decades, in fact, chiefly since the
introduction of serum immunoelectrophoresis, diagnosis of
multiple myeloma has greatly improved, but in the absence
of satisfactory knowledge on the causes of the disease, it is
difficult to assess whether there has been any real increase in
incidence (Turesson et al., 1984).
The only established risk factor for myeloma is ionising
radiation (Cuzick, 1981). A number of other risk factors have
been suggested, including occupational exposures - plastics,
rubber, petrochemical products, asbestos (Blattner, 1982) -
pesticides or employment in farming and agriculture (Boffetta
et al., 1989; Cuzick & De Stavola, 1988; Gallagher et al.,
1983; La Vecchia et al., 1989; Levi et al., 1988; Nandakumar
et al., 1986; Pearce et al., 1986; Steineck & Wiklund, 1986) or
in a variety of manufacturing industries (Blattner, 1982);
social class (MacMahon, 1966); and familial and genetic
factors (Blattner, 1982; Pottern & Blattner, 1985), but the
associations observed were moderate and (except for farming
and agriculture) inconsistent. It has also been suggested that
multiple myeloma could represent an uncontrolled or abnor-
mal immune response to chronic antigen stimulation, gener-
ally on the basis of laboratory evidence (Koepsell et al.,
1987) or case-reports (Koepsell et al., 1987; Penny & Hughes,
1970; Rosenblatt & Hall, 1970). A few analytical investiga-
tions on this topic reported significant relations between
multiple myeloma and a number of various medical condi-
tions, including several common autoimmune and chronic
diseases (in particular rheumatoid arthritis) (Hakulinen et al.,
1985), and some viral illnesses such as shingles (Cuzick & De
Stavola, 1988), or medical implants (Williams et al., 1989).
Further, family history of autoimmune diseases has also been
associated with multiple myeloma (Linet et al., 1988). How-
ever, other studies failed to confirm any general association
with chronic bacterial (Koepsell et al., 1987), viral or auto-
immune diseases (Cuzick & De Stavola, 1988; Linet et al.,
1987; Williams et al., 1989) or family history of autoimmune
diseases (Cuzick & De Stavola, 1989).
The present report, based on a hospital-based case-control
study conducted in Northern Italy, aimed to assess the
potential role of a variety of medical conditions on the risk
of multiple myeloma.
Subjects and methods
Since June 1983 we have been conducting a study on multiple
myeloma in Northern Italy within the framework of a case-
control surveillance of various lymphoid neoplasms, whose
general design has previously been described (La Vecchia et
al., 1989). Trained interviewers identified and questioned
patients admitted for multiple myeloma and for a wide spec-
trum of acute non-neoplastic conditions to a network of
university and general hospitals in the Greater Milan area.
Overall participation rate was over 97% for both cases and
controls. The present report is based on information collected
before December 1989.
Cases
These were patients with histologically confirmed multiple
myeloma, under age 80, diagnosed within the year before the
interview, admitted to the National Cancer Institute, to
several university clinics and to the Ospedale Maggiore, in-
cluding the four major general hospitals in the Greater Milan
area. A total of 117 cases (60 males and 57 females), aged
38-79 years (median age 63) was interviewed.
Controls
The comparison group comprised patients admitted for acute
conditions to the same network of hospitals. A total of 477
controls (337 males and 140 females), aged 27-79 (median
age 59) were interviewed. Of these, 26% were admitted for
traumas, 16% for non traumatic orthopaedic disorders, 24%
for surgical conditions, and 34% for other miscellaneous
illnesses including eye, ear, nose and throat, skin and dental
disorders. Table I give the distribution of controls according
to sex and main diagnostic categories.
A structured questionnaire was used, including socio-
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Table I Distribution of 477 controls according to diagnostic category
and sex. Milan, Italy, 1983-1989
Males Females
No. % No. %
Traumas 82 24.3 43 30.7
Other orthopaedic 50 14.8 26 18.6
conditions
Surgical conditions 75 22.3 40 28.6
Other miscellaneous 130 38.6 31 22.1
(eye, ENT, skin, dental)
demographic indicators, personal characteristics and habits
(tobacco, alcohol, coffee and other methylxanthine - contain-
ing beverages consumption), frequency of intake of a few
selected food items, and a problem-oriented occupational
exposure history. Further, the interview included a detailed
personal and family medical history based on a list of 42
disorders including common viral and bacterial illness,
chronic inflammatory conditions, autoimmune and allergic
disease. Immunisations, tonsillectomy and radiation exposure
for medical purposes were also elicited.
Data analysis
Relative risks (RR) of multiple myeloma, and the corre-
sponding 95% confidence intervals (CI) (Breslow & Day,
1980) according to various aspects of medical history were
estimated from data stratified for sex and age by means of
the Mantel-Haenszel procedure (Mantel & Haenszel, 1959).
Significance was assessed by the linear trend described by
Mantel (1963). Further, separate categories of various
diseases were defined according to their aetio-pathogenesis
(infectious, inflammatory or autoimmune), and their acute or
chronic pattern. The aim of this approach was to investigate
the different antigenic challenges among various aetiopatho-
genic agents. For bacterial illnesses, a summary score was
calculated on the basis of the number of diseases reported.
To account simultaneously for the potential confounding
effect of various risk factors, unconditional multiple logistic
regression, with multiple likelihood fitting, was applied to the
variables related to the risk of multiple myeloma (Baker &
Nelder, 1978; Breslow & Day, 1980). All the regression equa-
tions included terms for age, sex, area of residence and
education.
Results
Table II presents socio-demographic characteristics of cases
of multiple myeloma and controls. Compared to controls,
cases were older and somewhat more educated, but when
social class based on the head of household's occupation was
considered no appreciable differences emerged. Smoking was
not associated with the risk of multiple myeloma (data not
shown).
Table III shows the relation between multiple myeloma
and history of selected infectious diseases. No association
emerged with any of the common childhood viral illnesses
(chickenpox, mumps, measles, rubella, infectious mono-
nucleosis), and the RRs tended to be below unity for most
diseases. There was only a non significant excess of myeloma
risk for episodes of Herpes zoster infection (RR = 1.8; 95%
CI = 0.9-3.5). With regard to bacterial diseases, scarlet fever
was associated with significant elevation in risk (RR = 2.0;
95% CI = 1.1-3.9); in addition, a higher percentage of cases
than controls reported past diagnosis of tuberculosis (6.8 vs
2.7%), pyelonephritis (2.6 vs 0.8%), and malaria (6.0 vs
3.6%), but the 95% confidence intervals of the relative risk
included unity. No significant differences emerged as regards
past history of any autoimmune or chronic inflammatory
conditions (such as rheumatoid arthritis, systemic lupus ery-
thematosus, scleroderma, Sjogren's disease, pernicious anae-
mia, dermatomyositis, ulcerative colitis etc. ; data not shown).
Table II Distribution of 117 cases of multiple myeloma and 477
controls according to sex, age group, education and social class.
Milan, Italy 1983-1989
Males Females
Cases Controls Cases Controls
No. (%) No. (%) No. (%) No. (%)
Age group (yrs)
< 50 7 (11.7) 104 (30.9) 8 (14.0) 46 (32.9)
50-59 18 (30.0) 74 (22.0) 13 (22.8) 21 (15.0)
60-69 21 (35.0) 109 (32.3) 15 (26.3) 34 (24.3)
70 14 (23.3) 50 (14.8) 21 (36.8) 39 (27.9)
Education (yrs)
<7 41 (68.3) 202 (59.9) 42 (73.7) 91 (65.0)
7-11 7 (11.7) 84 (24.9) 8 (14.0) 31 (22.1)
12 12 (20.0) 51 (15.1) 7 (12.3) 18 (12.9)
Social class
I or II 24 (40.0) 118 (35.0) 15 (26.3) 45 (32.1)
III 26 (43.3) 182 (54.0) 28 (49.1) 59 (42.1)
IV or V 7 (11.7) 34 (10.1) 9 (15.8) 29 (20.7)
Other 3 (5.0) 3 (0.9) 5 (8.8) 7 (5.0)
Table III Relative risk of multiple myeloma in relation to history of
selected infectious diseases. Milan, Italy 1983-1989
No (%) of subjects with Relative risk
the disease estimates*
Cases Controls (95% CI)
Viral infections:
Chickenpox 42 (35.9) 226 (47.4) 0.7
(0.5-1.1)
Mumps 45 (38.5) 195 (40.9) 1.0
(0.7-1.6)
Measles 69 (59.0) 285 (59.7) 1.0
(0.6-1.5)
Rubella 15 (12.8) 68 (14.3) 0.8
(0.5-1.4)
Infectious 2 (1.7) 3 (0.6) 0.4
mononucleosis (0.1-2.6)
Herpes zoster 14 (12.0) 29 (6.1) 1.8
(shingles) (0.9-3.5)
Bacterial infections:
Whooping-cough 35 (29.9) 135 (28.3) 1.1
(0.7-1.7)
Scarlet fever 17 (14.5) 39 (8.2) 2.0
(1.1-3.9)
Rheumatic fever 9 (7.7) 23 (4.8) 1.4
(0.6-3.2)
Pyelonephritis 3 (2.6) 4 (0.8) 2.0
(0.5-8.4)
Tuberculosis 8 (6.8) 13 (2.7) 2.3
(0.9-5.7)
Typhus/parathypus 9 (7.7) 28 (5.9) 1.2
(0.6-2.6)
Chronic bronchitis 15 (12.8) 51 (10.7) 1.3
(0.7-2.4)
Malaria 7 (6.0) 17 (3.6) 1.8
(0.7-4.5)
*Mantel-Haenszel estimates adjusted for age and sex.
When various classes of infectious or inflammatory
diseases were grouped together (Table IV) according to
selected criteria, no significant association was observed for
acute bacterial diseases (RR= 1.2; 95% CI = 0.8-1.8). A
significantly elevated risk was found for chronic bacterial
disease, including tuberculosis, pyelonephritis, rheumatic
fever and chronic bronchitis (RR = 1.8; 95% CI = 1.1-2.8).
Relative risk estimates appeared to increase steadily with the
number of bacterial diseases with a RR of 3.8 (95% CI =
1.3-10.8) for a history of more than two. The risk estimates
were above unity, although not significantly, for chronic
inflammatory (RR = 1.6) and autoimmune (RR = 1.3)
diseases. A negative association of borderline significance was
found for history of allergies (drug and food allergies,
asthma and eczema, RR = 0.6, 95% CI 0.3-1.0).
The conditions showing significant associations with multi-
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Table IV Relative risk of multiple myeloma in relation to history of
various diseases. Milan, Italy 1983-1989
No (%) of subjects with Relative risk
the disease estimates*
Cases Controls (95% CI)
Any viral infectiona 81 (69.2) 360 (75.5) 0.8
(0.5- 1.3)
Acute bacterial diseasesb 47 (40.2) 173 (36.3) 1.2
(0.8-1.8)
Chronic bacterial diseasesc 26 (22.2) 65 (13.6) 1.8
(1.1 -2.8)
Any bacterial diseased
1 36 (30.8) 168 (35.2) 0.8
(0.5- 1.6)
2 15 (12.8) 40 (8.4) 1.5
(0.7-3.0)
>2 7 (6.0) 7 (1.5) 3.8
(1.3- 10.8)
XAI (trend) 4.5(P = 0.04)
Chronic inflammatory 21 (17.9) 57 (11.9) 1.6
diseasese (0.9-3.1)
Autoimmune diseases' 17 (14.5) 44 (9.2) 1.3
(0.7-2.3)
Allergic conditionsg 17 (14.5) 98 (20.5) 0.6
(0.3-1.0)
*Mantel-Haenszel estimates adjusted for age and sex. aIncludes viral
infections considered in Table II. bIncludes whooping-cough, scarlet
fever and typhus/paratyphus. clncludes tuberculosis, pyelonephritis and
chronic bronchitis. dIncludes acute and chronic bacterial diseases.
'Includes rheumatic fever, ulcerative colitis, multiple sclerosis, glome-
rulonephritis, peptic ulcer and Raynaud's disease. fIncludes systemic
lupus erythematosus, scleroderma, polyarteritis, rheumatoid arthritis,
thyroiditis, pernicious anemia, miasthenia gravis, thrombocytopenia
and Sjogren's disease. gIncludes drug and food allergies, asthma and
eczema.
ple myeloma were further considered in Table V in relation
to time elapsed since tumour diagnosis. For episodes of
Herpes zoster infection, the risk was higher among subjects
whose diagnosis dated back less than 10 years. For tuber-
culosis the strength of the association was comparable for
diagnoses dating back to short or long time before diagnosis
of multiple myeloma. For scarlet fever, chronic bacterial and
allergic conditions, the first episode dated back more than 10
years in all cases.
The analysis of immunisation against infectious disease is
presented in Table VI. Only for BCG was the relative risk
significantly above unity. No consistent associations were
seen for other vaccinations, including smallpox, polio,
tetanus and diptheria.
None of the significant associations was appreciably modi-
fied by allowance for major identified potential confounding
factors using multiple logistic regression, although multi-
variate risk estimate for BCG immunisation was apparently
higher (Table VII).
Table V Relative risk of multiple myeloma in relation to history of
selected diseases according to time since diagnosis. Milan, Italy,
1983- 1989
No (%) of subjects with Relative risk
Years since the diseaset estimates*
diagnosis Cases Controls (95% CI)
Episodes of <10 8 (6.8) 4 (0.8) 5.0
Herpes zoster (1.6-15.9)
infection 10 5 (4.3) 25 (5.2) 0.8
(0.3-2.1)
Tuberculosis <10 1 (0.8) 1 (0.2) 3.7
(0.2-65.5)
10 6 (5.1) 12 (2.5) 1.8
(0.7-5.1)
tFigures do not add up to the total because of a few missing values.
*Mantel-Haenszel estimates adjusted for age and sex.
Table VI Relative risk of multiple myeloma in relation to history of
various immunisations. Milan, Italy, 1983-1989
No (%) of subjects Relative risk
reporting exposure estimates*
Immunisations Cases Controls (95% CI)
Smallpox 91 (77.8) 398 (83.4) 0.7
(0.4-1.3)
Poliomielitis 28 (23.9) 113 (23.7) 0.9
(0.6- 1.4)
Tetanus 70 (59.8) 372 (78.0) 0.6
(0.4-1.0)
Diphteria 10 (8.5) 68 (14.3) 0.9
(0.4-1.8)
BCG 11 (9.4) 24 (5.0) 3.0
(1.4-6.4)
*Mantel-Haenszel estimates adjusted for age and sex.
Table VII Multivariate relative risks of multiple myeloma according
to selected diseases or immunisations
Disease or immunisation MLR* (95% CI)
Chickenpox 0.7 (0.5-1.1)
Herpes zoster (shingles) 1.6 (0.8-3.3)
Scarlet fever 1.9 (1.0-3.6)
Tuberculosis 2.2 (0.9-5.8)
Malaria 1.6 (0.6-4.2)
Chronic bacterial diseasesa 1.8 (1.0-3.0)
Chronic inflammatory diseasesa 1.5 (0.9-2.8)
Any bacterial diseasea:
1 0.9 (0.6-1.5)
2 1.4 (0.7-2.8)
>2 4.4 (1.4-13.7)
Allergic conditionsa 0.6 (0.3-1.1)
BCG immunisation 7.1 (2.6-19.0)
Tetanus immunisation 0.7 (0.4-1.1)
*Estimates from mutiple logistic regression equations including terms
for age, sex, area of residence and education, plus the above listed
conditions. aSee footnote to Table III.
Discussion
The results of this study suggest a moderate positive associa-
tion between multiple myeloma risk and some conditions
such as tuberculosis, malaria and chronic inflammatory (par-
ticularly bacterial) diseases: An inverse relationship on the
borderline of significance was found with allergic disorders.
These findings should be viewed with caution in considera-
tion of the small number of cases and the methodological
limits of the study, including the fact that it was not popu-
lation-based and that information was derived from interview
only, in the absence of validation by serology or from orig-
inal medical records. Still, hospital-based studies may well
represent an optimal design for the analysis of medical condi-
tions, since cases and controls are similarly sensitised towards
recalling diseases occurred in the past as shown by a reli-
ability analysis of data obtained from a large hospital-based
case-control study conducted in the United States, Canada
and Israel (Kelly et al., 1990). Nonetheless, information bias
cannot be totally excluded since cases might on the whole be
more careful than controls with acute non-neoplastic condi-
tions in recalling histories of various diseases, and (though
difficult to quantify) this bias may well explain associations
of the order of those observed in this study. Further, in this
investigation cases and controls came from a comparable
catchment area, participation rate was almost complete and
no known confounding factors could account for the observ-
ed association.
A relationship between tuberculosis and multiple myeloma
risk is not widely recognised. The fact that relative risk was
similarly elevated for tuberculosis occurring less than 10 or
more years before diagnosis of multiple myeloma weighs
against the possibility of this being an early manifestation of
the disease. The elevated risk associated with BCG
immunisation may also represent an indirect indicator of
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exposure to tuberculosis, particularly since some confusion
between it and a tuberculin test is likely in patients' recall. In
contrast, as observed in a case-control study conducted in
England and Wales (Cuzick & De Stavola, 1988), the finding
of an excess of shingles in the 10 years before diagnosis
suggests that it may indeed constitute an early manifestation
of myeloma rather than a cause of it. In agreement with
some recent reports (Boffetta et al., 1989; Linet et al., 1987),
our analysis did not confirm the association with chronic
immunological diseases, such as rheumatoid arthritis, sug-
gested by some case reports and epidemiological studies
(Hakulinen et al., 1985). This could well be explained by the
heterogeneity of multiple myeloma diagnosis which includes
various and perhaps etiologically distinct subclasses, e.g. IgG
or IgA or light chain myeloma. The play of chance may be
important too, in the presence of moderate associations for a
complex of variables with inherent difficulties in data collec-
tion.
Finally, our investigation showed an inverse relationship
between allergic conditions and multiple myeloma risk, in
contrast with some studies which suggested elevated risk of
myeloma with asthma or allergies in general (Gallagher et al.,
1983). Although our results should be interpreted with great
caution, a similar protective relationship has been observed
for pancreatic and liver cancer (La Vecchia et al., 1990b;
Mack et al., 1986; Mills et al., 1988). However, further
studies on the topic are needed before one can do any more
than speculate about a possible protective effect of immuno-
logical correlates of allergies and the risk of several hetero-
geneous cancers.
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